Within these broad categories, protein binding and ATP binding were the major biomolecular binding functions affected by differentially expressed transfrags with node scores of 244 and 226 respectively.
Combining CG and DHS into one model readily explains over two thirds (68% genome wide and 60% at CG rich regions) of the methylation variations observed in mESCs suggesting that CG density and TF binding are the major determinants of genomic methylation.
VEGF-A, a heparin/HS-binding glycoprotein, is the major pro-angiogenic growth factor that controls the development of extra-retinal NV in OIR [21], [22], [25].
Sex hormone-binding globulin is the major transport protein of oestradiol, and is thus inversely related to free oestradiol, the fraction of oestradiol that is not bound and thus is most biologically active.
Insulin-like growth factor binding protein 3 is the major binding protein for insulin-like growth factors in the blood and also has IGF-independent apoptotic effects.
The vitamin D binding protein (DBP) is the major plasma carrier for vitamin D and its metabolites, but it is also an actin scavenger, and is the precursor to the immunomodulatory protein, Gc-MAF.
The higher proportions that were active when binding site motifs were conserved are consistent with our conclusion that binding by a key TF is the major determinant of enhancer activity.
It is shown that V4 has high binding affinity for LPS, which is the major component of the outer membrane of Gram-negative bacteria, and shows selectivity for negatively charged lipids in contrast to zwitterionic lipids at a low peptide/lipid ratio.
The larger molecular size peak fraction of β-catenin reflects β-catenin/α-catenin dimers, as this peak perfectly cofractionates with α-catenin (Fig. 2A), shRNA knock-down of α-catenin eliminates this size fraction of β-catenin (Fig. 2B & C), and α-catenin is the major binding partner of β-catenin in these cells (Fig. 2D).
